March 7th, 2022
Wyss Institute’s eRapid sensor technology licensed to Antisoma Therapeutics
Low-cost, multiplexed, electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Licensing
February 23rd, 2022
Cantex licenses IP from Harvard to develop repurposed drug identified by Wyss Institute to treat inflammatory lung diseases including COVID-19
Organ Chip studies revealed azeliragon can reduce virus-associated inflammation in human lung tissue
February 10th, 2022
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
Novel delivery of established growth and neurotropic factors enables local, sustained release for greater efficacy
June 2nd, 2021
Harvard licenses technology to Obatala Sciences to advance discovery in obesity, diabetes, and cancer
Development by New Orleans biotech company to enable studies of human fat tissue in vitro
January 15th, 2021
Leading universities launch joint technology licensing program
UTLP pools a subset of universities' intellectual property portfolios in the areas of connectivity, autonomous vehicles, and data applications
